2-(5-(4-aminophenyl)-2H-tetrazol-2-yl)-N-(5-methylisoxazol-3-yl)acetamide

ID: ALA4471644

Chembl Id: CHEMBL4471644

Cas Number: 436092-90-9

PubChem CID: 858292

Max Phase: Preclinical

Molecular Formula: C13H13N7O2

Molecular Weight: 299.29

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cc(NC(=O)Cn2nnc(-c3ccc(N)cc3)n2)no1

Standard InChI:  InChI=1S/C13H13N7O2/c1-8-6-11(18-22-8)15-12(21)7-20-17-13(16-19-20)9-2-4-10(14)5-3-9/h2-6H,7,14H2,1H3,(H,15,18,21)

Standard InChI Key:  KWRKZOVHYGIXIE-UHFFFAOYSA-N

Associated Targets(non-human)

Falcipain 2 (539 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cysteine protease falcipain-3 (103 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 299.29Molecular Weight (Monoisotopic): 299.1131AlogP: 0.86#Rotatable Bonds: 4
Polar Surface Area: 124.75Molecular Species: NEUTRALHBA: 8HBD: 2
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 8.77CX Basic pKa: 2.52CX LogP: 1.67CX LogD: 1.65
Aromatic Rings: 3Heavy Atoms: 22QED Weighted: 0.68Np Likeness Score: -2.94

References

1. Gao C, Chang L, Xu Z, Yan XF, Ding C, Zhao F, Wu X, Feng LS..  (2019)  Recent advances of tetrazole derivatives as potential anti-tubercular and anti-malarial agents.,  163  [PMID:30530192] [10.1016/j.ejmech.2018.12.001]

Source